BioMarin Pharmaceutical | Resultado Líquido



Net Income Alterar Data
Acadia Pharmaceuticals USD 26.67M 7.68M 2025-06
Agios Pharmaceuticals USD -112020000 22.73M 2025-06
Alnylam Pharmaceuticals USD -66277000 8.8M 2025-06
Amgen USD 1.43B 298M 2025-06
Bayer EUR -199000000 1.5B 2025-06
Biogen USD 634.8M 394.3M 2025-06
BioMarin Pharmaceutical USD 240.53M 54.85M 2025-06
Gilead Sciences USD 1.96B 645M 2025-06
Incyte USD 405M 246.8M 2025-06
Insmed USD -321686000 65.1M 2025-06
Ionis Pharmaceuticals USD 123.55M 270.49M 2025-06
Moderna USD -825000000 146M 2025-06
Neurocrine Biosciences USD 107.5M 99.6M 2025-06
PTC Therapeutics USD -64849000 931.41M 2025-06
Regeneron Pharmaceuticals USD 1.39B 582.9M 2025-06
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 499M 2.32B 2024-12
Sarepta Therapeutics USD 196.89M 644.4M 2025-06
Ultragenyx Pharmaceutical USD -114951000 36.13M 2025-06
United Therapeutics USD 309.5M 12.7M 2025-06
Vertex Pharmaceuticals USD 1.03B 386.6M 2025-06


BioMarin Pharmaceutical Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.